Samir Saba
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Samir Saba sits in the upper quartile of US sponsors by registered trial count (#2,913 of 15,742 sponsors by registered trial count).
Samir Saba: 4 sponsored US clinical trials, 1 recruiting.
Samir Saba sponsors 4 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 3 completed. The most-studied condition in this pipeline is Acute Myocardial Infarction, with 1 trials.
Upper-quartile sponsor footprint
Samir Saba sits in the upper quartile of the sponsor corpus (#2,913 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
4 total, page 1 of 1
Arrhythmia Detection After MI
NCT05073419
Improvement in Endothelial Dysfunction After Initiation of Anti-arrhythmic Therapy in Atrial Fibrillation Patients
NCT04128878
Cardiac Resynchronization in the Elderly
NCT03031847
Predictors of Response to Biventricular Pacing in Heart Failure
NCT00156390
Therapeutic Areas
What is open in the Samir Saba pipeline
1 recruiting of 4 indexed (25% open); 3 completed (75%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Acute Myocardial Infarction (1 trial), 0 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Samir Saba: open-pipeline peers nationwide
Peers matched on 4 registered trials and 25% open enrollment, not the therapeutic-area sidebar.
Samir Saba sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 4 trials (± recruiting share)
- 4D pharma · 4 trials · 0% recruiting
- 60 Degrees Pharmaceuticals · 4 trials · 50% recruiting
- A2 Biotherapeutics · 4 trials · 75% recruiting
- Abdul Latif Jameel Poverty Action Lab · 4 trials · 25% recruiting
Sponsors near 25% open enrollment (± trial volume)
- AB Science · 25% recruiting · 8 trials
- Abbott Point of Care · 25% recruiting · 8 trials
- Accutar Biotechnology · 25% recruiting · 4 trials
- Adrienne G. Waks · 25% recruiting · 4 trials
Related
What to do with this Samir Saba page
4 registered trials is a research-attention snapshot, not an endorsement of Samir Saba or any single study.
- 1 of Samir Saba's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Acute Myocardial Infarction is the condition Samir Saba studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Acute Myocardial Infarction trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Samir Saba pipeline card: 4 registered trials from official public datasets.Report a data error.